What was the market valuation of the US malaria diagnostics market in 2024?

The market valuation was $7.05 Million in 2024. Read More

What is the projected market valuation for the US malaria diagnostics market in 2035?

The projected valuation for 2035 is $13.71 Million. Read More

What is the expected CAGR for the US malaria diagnostics market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period is 6.23%. Read More

Which technology segment is anticipated to show the highest growth in the US malaria diagnostics market?

The Rapid Diagnostic Tests segment is expected to grow from $2.82 Million in 2024 to $5.38 Million by 2035. Read More

How do the revenues from microscopy compare to those from polymerase chain reaction in the US malaria diagnostics market?

Microscopy revenues were $1.05 Million in 2024, while polymerase chain reaction revenues were $1.26 Million. Read More

What was the revenue for test kits in the US malaria diagnostics market in 2024?

The revenue for test kits was $2.82 Million in 2024. Read More

Which company is a key player in the US malaria diagnostics market?

Roche is one of the key players in the US malaria diagnostics market. Read More

What is the expected revenue growth for reagents in the US malaria diagnostics market by 2035?

Revenues for reagents are projected to increase from $2.11 Million in 2024 to $4.05 Million by 2035. Read More

What applications are driving the US malaria diagnostics market?

Applications driving the market include Clinical Diagnosis, Epidemiological Studies, and Drug Efficacy Studies. Read More

US Malaria Diagnostics Market

Q: What are the key end-user segments in the US malaria diagnostics market?

Key end-user segments include Hospitals, Diagnostic Laboratories, Research Institutes, and Home Care Settings. Read More

US Malaria Diagnostics Market Research Report: Size, Share, Trend Analysis By Technology (Rapid Diagnostic Tests, Microscopy, Polymerase Chain Reaction, Serology Tests, Loop-Mediated Isothermal Amplification), By End Users (Hospitals, Diagnostic Laboratories, Research Institutes, Home Care Settings), By Product Type (Test Kits, Reagents, Instruments) and By Applications (Clinical Diagnosis, Epidemiological Studies, Drug Efficacy Studies) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

6.23%

2024 Market Size

$ 7.05 Million

2035 Market Size

$ 13.71 Million

Life Sciences ● Updated August 2026 Report ID: MRFR/LS/13113-HCR | Pages: 100 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Technology (USD Million)
  1. 4.1.1 Rapid Diagnostic Tests
  2. 4.1.2 Microscopy
  3. 4.1.3 Polymerase Chain Reaction
  4. 4.1.4 Serology Tests
  5. 4.1.5 Loop-Mediated Isothermal Amplification
2. 4.2 Chemicals and Materials, BY End User (USD Million)
  1. 4.2.1 Hospitals
  2. 4.2.2 Diagnostic Laboratories
  3. 4.2.3 Research Institutes
  4. 4.2.4 Home Care Settings
3. 4.3 Chemicals and Materials, BY Product Type (USD Million)
  1. 4.3.1 Test Kits
  2. 4.3.2 Reagents
  3. 4.3.3 Instruments
4. 4.4 Chemicals and Materials, BY Application (USD Million)
  1. 4.4.1 Clinical Diagnosis
  2. 4.4.2 Epidemiological Studies
  3. 4.4.3 Drug Efficacy Studies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Roche (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Abbott (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 BD (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cepheid (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hologic (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Thermo Fisher Scientific (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Diatheva (IT)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 US MARKET ANALYSIS BY END USER
4. 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF CHEMICALS AND MATERIALS
9. 6.9 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
12. 6.12 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 CHEMICALS AND MATERIALS, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
14. 6.14 CHEMICALS AND MATERIALS, BY END USER, 2024 (% SHARE)
15. 6.15 CHEMICALS AND MATERIALS, BY END USER, 2024 TO 2035 (USD Million)
16. 6.16 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 (% SHARE)
17. 6.17 CHEMICALS AND MATERIALS, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
18. 6.18 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
19. 6.19 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Million)
  2. 7.2.2 BY END USER, 2025-2035 (USD Million)
  3. 7.2.3 BY PRODUCT TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Malaria Diagnostics Market Segmentation

US Malaria Diagnostics Market By Technology (USD Million, 2025-2035)

Rapid Diagnostic Tests
Microscopy
Polymerase Chain Reaction
Serology Tests
Loop-Mediated Isothermal Amplification

US Malaria Diagnostics Market By End User (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutes
Home Care Settings

US Malaria Diagnostics Market By Product Type (USD Million, 2025-2035)

Test Kits
Reagents
Instruments

US Malaria Diagnostics Market By Application (USD Million, 2025-2035)

Clinical Diagnosis
Epidemiological Studies
Drug Efficacy Studies

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”